Naltrexone/Bupropion

被引：0
|
作者：
不详
机构：
来源：
DRUGS IN R&D | 2010年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In March 2010, Orexigen (R) Therapeutics submitted a new drug application (NDA) for approval of naltrexone sustained release (SR)/bupropion SR (Contrave (R)) for the treatment of obesity in the US. The tablet contains naltrexone SR 32mg and bupropion SR 360 mg. The drug has been tested in four randomized, double-blind, placebo-controlled, phase III trials and the coprimary endpoints were met in each case. This review discusses the key development milestones and clinical trial program to date.
引用
收藏
页码：25 / 32
页数：8
相关论文
共 50 条
  • [11] Combination therapy with naltrexone and bupropion for obesity
    Billes, Sonja K.
    Greenway, Frank L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1813 - 1826
  • [12] Naltrexone and bupropion reduce the prevalence of the metabolic syndrome
    Greenway, Frank L.
    Erickson, Janelle
    Duna-Yevich, Eduardo
    Tollefson, Gary
    DIABETES, 2008, 57 : A738 - A738
  • [13] Characterization of the Effect of Naltrexone/Bupropion on Body Composition
    Tsoukas, Michael
    Tardio, Vanessa
    Fils-Aime, Nadege
    Burrows, Melonie
    Blavignac, Jessica
    Camacho, Fernando
    Gould, Errol
    Barakat, Maxime
    OBESITY, 2020, 28 : 66 - 66
  • [14] ANALYSIS OF COMBINATION OF NALTREXONE WITH BUPROPION FOR WEIGHT LOSS
    Pirzada, Hannah
    Anwar, Saeed
    ul Hasan, Nadeem
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 10275 - 10278
  • [15] Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?
    El Hayek, Samer A.
    Shatila, Malek A.
    Adnan, Jana A.
    Geagea, Luna E.
    Kobeissy, Firas
    Talih, Farid R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (09) : 737 - 749
  • [16] Naltrexone/bupropion increases risk of serious AEs
    Reactions Weekly, 2020, 1788 (1) : 8 - 8
  • [17] Characterization of the effect of naltrexone/bupropion on body composition
    Tardio, Vanessa
    Yin, Peter
    Camacho, Fernando
    Barakat, Maxime
    Tsoukas, Michael A.
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2397 - 2404
  • [18] Contrave - A Combination of Bupropion and Naltrexone for Weight Loss
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 112 - 114
  • [19] Naltrexone/bupropion could affect ability to drive
    Reactions Weekly, 2019, 1768 (1) : 4 - 4
  • [20] Role of Bupropion Plus Naltrexone for the Management of Obesity
    Booth, Kemper
    Clements, Jennifer N.
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (03) : 125 - 132
12345